Objective: Systematic reviews are an appraised method to summarize research in a concise and transparent way, and may enable to draw conclusions beyond the sum of results of individual studies. We assessed the results, quality and external validity of systematic reviews on diet in patients with type 2 diabetes. Design, setting, subjects: We systematically searched for systematic reviews on nutritional interventions in patients with type 2 diabetes that used a reproducible search strategy in at least one major database that applied some form of quality assessment. We assessed quality and the external validity of the retrieved systematic reviews. Outcomes were defined as statistical metaanalyses or narrative results using a predefined and reproducible method. Results: Six systematic reviews met the inclusion criteria, investigating dietary interventions in general (n ¼ 3), chromium supplementation (n ¼ 1), fish-oil (n ¼ 1) or herbs and nutrition supplements (n ¼ 1). Quality assessment showed minimal/minor flaws in four cases and major/extensive flaws in two cases. All reviews had insufficient data needed to judge external validity. In reviews with minimal/minor flaws, we found beneficial effects of very-low-calorie diets and fish-oil supplements. However, the external validity of these results could not be assessed sufficiently. Conclusions: Systematic reviews largely failed to produce knowledge beyond the sum of the original studies. Furthermore, judgment of external validity was hampered in most cases owing to missing data. To improve the quality and usefulness of systematic reviews of dietary interventions, we recommend the application of more focused research questions, but with broader inclusion criteria, for example, the use of observational studies.
Introduction
Diet is an important aspect in the management of type 2 diabetes. It is directly related to main treatment goals such as the establishment of a (near) normal body weight, control of plasma lipids and hyperglycaemia, renal protection and the avoidance of hypoglycaemic episodes (Franz et al., 2002) . In order to establish beneficial dietary changes in patients with type 2 diabetes, a clinician has to be informed about many aspects of diet in type 2 diabetes, including the effects of macro-and micronutrients and food supplements. In addition, it is important to know how to bring about persistent beneficial changes in patients' dietary habits.
It is virtually impossible for both researcher and clinician to keep track of all published research in the field. Systematic reviews offer an appraised method to summarize all relevant studies in a concise and transparent way, and they may enable to draw conclusions beyond the sum of results of individual studies. In addition, systematic reviews may help researches to refine hypotheses, estimate sample sizes and help to define future research agendas .
In the last decade, systematic reviews became increasingly popular. For example, the Cochrane library, a collection of regularly updated high-quality systematic reviews, has grown from 36 systematic reviews in 1995 to 2356 systematic reviews in 2005 (4% of which dealt with nutrition (Summerbell et al., 2005) ). A quick look in Pubmed (Medical Subject Heading 'diabetic diet') revealed more reviews (n ¼ 485) than clinical trials (n ¼ 360). Also, there is an increased awareness of the impact of systematic reviews for practice and research as can be read from different editorials in leading journals Clarke and Horton, 2001) . And, in an attempt to improve the uniformity and completeness of the reporting of systematic reviews, an evidence-based guideline was developed (Moher et al., 1999) .
It is important to distinguish systematic reviews from narrative reviews: in contrast to narrative reviews, systematic reviews should have a clear and narrow research question and should be conducted by a reproducible method. Therefore, systematic reviews are considered a scientific exercise in itself. However, still a considerable amount of so-called systematic reviews, especially those sponsored by the industry or non-Cochrane reviews, appear to have methodological flaws (Jadad et al., 2000) . Moreover, studies on the same topic that were found to be of good quality may produce contradictory evidence (Jadad and McQuay, 1996; Furlan et al., 2001) .
In this study, we systematically searched and critically appraised all systematic reviews on the topic of type 2 diabetes and diet. Our aims were to establish the highest levels of evidence by means of systematic reviews for different topics on diet and type 2 diabetes, to identify research gaps and to analyze methodological problems in systematic reviews of studies in the nutrition field.
Methods

Search strategy
We searched PUBMED (which contains MEDLINE and a number of additional journals), EMBASE and the Cochrane Database of Abstracts of Review of Effects (DARE). In addition, we checked bibliographies from guidelines and known reviews, we contacted experts in the fields and we searched our own personal files. We used a combined sensitive search strategy for 'systematic reviews', 'type 2 diabetes' and 'dietary interventions' (See Supplementary information for Appendix A). The last search was in December 2005 for PUBMED and DARE, and in October 2005 for EMBASE. Two independent reviewers (FVDL, JVB) assessed all titles and abstracts and extracted all data. Interrater agreement was calculated by k-statistics. If a study could not be excluded on basis of title and/or abstract alone, we retrieved the full article for further assessment.
The inclusion criteria were: (1) studies primarily aiming to review the literature, (2) using a reproducible search strategy, in (3) at least one major electronic database (MEDLINE, EMBASE or CENTRAL), (4) the main focus should be on a nutritional intervention in patients with type 2 diabetes (reviews that studied interventions to change eating habits and/or reduce body weight, and studies assessing the effects of a specific food composition or foodstuff (e.g. fish-oil) were included) and (5) there should be some form of assessment of the quality of included studies. This way, systematic reviews were distinguished from narrative ones.
We excluded studies in another language than English, Dutch, German French or Italian.
Data extraction and quality assessment Two reviewers (FVDL, JVB) extracted independently all data and assessed quality on a pre-tested data extraction form. Cases of disagreement were resolved by consensus or by consultation of the third reviewer (RA). We extracted the following items: (1) General aspects: language, sponsor and background of authors. (2) Methods/quality items: sources used, inclusion criteria, exclusion criteria and restrictions (language, unpublished studies), number of reviewers that assessed abstracts and extracted data, handling of missing data, method of quality assessment, method of investigating and handling heterogeneity (including heterogeneity caused by differences in setting), statistical method of meta-analyses, method of incorporating quality items in results. External validity: setting (e.g. general practice, hospital), patients (e.g. duration of type 2 diabetes), type of intervention, length of follow-up. (3) Outcome assessment: outcomes were first subdivided in type of intervention (e.g. very-low-calorie diet, lowglycemic index diet, etc.); next we clustered the result per type of intervention (e.g. effect on body weight, effect on blood glucose). We considered the following as being an outcome from a systematic review: (A) numeric data from meta-analyses with appropriate handling of possible heterogeneity or (B) an overall judgment of the effect of a certain intervention, using a predefined method, ideally taking into account quality and heterogeneity. A straightforward list of the results and/or conclusions of the included studies was not considered to be a result of a systematic review. The following outcomes were extracted: mortality, diabetes-related morbidity (cardiovascular disease, nephropathy, retinopathy, neuropathy) and quality of life, body weight (or body mass index), indicators for blood glucose (glycated. hemoglobin, blood glucose, plasma insulin), risk factors for cardiovascular disease (plasma lipids, blood pressure), indicators for renal disease (creatinin) and compliance.
Overall quality was assessed with the Overview Quality Assessment Questionnaire (OQAQ), a validated tool for the critical appraisal of systematic reviews (Oxman and Guyatt, 1991) . The instrument consisted of nine questions (yes, no, cannot tell) about different aspects of the methodological quality and one overall score rated from 1 (extensive flaws) to 7 (minimal flaws). Both reviewers discussed and rated all included studies. In case of disagreement, a third reviewer (RA) was consulted. In addition, we assessed whether and how heterogeneity was assessed, and we evaluated whether and how the results of the quality assessment were incorporated in the results.
External validity is the extent to which results are applicable to other circumstances. It cannot be formally tested and judgment depends on study aspects with respect to patients, treatment regimens, settings and length of follow-up (Egger et al., 2001) . Although, no guideline for formal assessment of external validity exists, we attempted to gain insight into external validity by recording whether the systematic reviews assessed the following characteristics of included studies: patient characteristics (age, sex, duration of diabetes, body weight), details of treatment regimens, setting (country, level of care) and length of follow-up.
Results
The search in PUBMED, EMBASE and DARE, resulted in 153, 1533 and 166 records, respectively. In EMBASE, the number of records was significantly higher compared with other sources because the search string for 'systematic reviews' was made less specific owing to browser differences. The k for interrater agreement was 0.87 (95% confidence interval (CI) 0.73-1.00). We included six systematic reviews (Table 1 ) (Brown et al., 1996; Montori et al., 2000; Farmer et al., 2001; Althuis et al., 2002; Yeh et al., 2003; Moore et al., 2004; Norris et al., 2004) .Two articles referred to the same systematic review (Montori et al., 2000; Farmer et al., 2001) . Ten other systematic reviews were initially included, but excluded after reading the full article: seven systematic reviews because it was unclear whether and how quality assessment performed (Waugh and Robertson, 1997; Friedberg et al., 1998; Garg, 1998; Brand-Miller et al., 2003; Anderson et al., 2004; Venn and Mann, 2004; Guerrero-Romero and Rodriguez-Moran, 2005) , one because its focus was on both diabetic and non-diabetic renal disease (Pedrini et al., 1996) , one systematic review did not study the effects of diet, but the impact of weight gain in patients with diabetes (Anderson et al., 2003) , and one systematic review focused on enteral nutritional support for specific subgroups of patients with diabetes (e.g. postoperative, slow-healing ulcers) (Elia et al., 2005) .
All other records were excluded on basis of the title and/or abstract. We kept track of the reasons for exclusion for a random sample of 50 records for each database. The possible reasons were: (1) the study was not a systematic literature review, (2) the study did not focus on patients with type 2 diabetes, (3) the study did not focus on a dietary intervention or (4) a combination of two or three of the previously mentioned reasons. This yielded the following results for PUBMED: (1) 14%, (2) 14%, (3) 10%, (4) 62%; EMBASE: (1) 6%, (2) 0%, (3) 10%, (4) 84%; DARE: (1) 0% (DARE only includes systematic reviews), (2) 72%, (3) 2%, (4) 26%.
Characteristics and quality of systematic reviews (Tables 1 and 2 ) Of the six included systematic reviews two focused on strategies, including diet, that promote weight loss in patients with type 2 diabetes (Brown et al., 1996; Norris et al., 2004) . One investigated dietary advice in general (Moore et al., 2004) , and three other studies focused on the effects of specific dietary interventions: the use of chromium supplements (Althuis et al., 2002) , fish-oil supplements (Farmer et al., 2001) , both herbal remedies and dietary supplements (Yeh et al., 2003) .
In all systematic reviews, more than one source had been used: varying from two major electronic databases and reference checking (Althuis et al., 2002) , to searching in nine databases (Norris et al., 2004) . The inclusion of studies in the systematic review differed widely: four of six reviews included only randomized studies, the other two also included non-randomized studies (Brown et al., 1996; Yeh et al., 2003) . All systematic reviews selected studies in type 2 diabetic patients, but in addition also studies with healthy volunteers (Althuis et al., 2002; Yeh et al., 2003) , and patients with impaired glucose tolerance or type 1 diabetes were included (Yeh et al., 2003) . One review restricted inclusion to studies with obese patients with type 2 diabetes (Brown et al., 1996) . Three reviews applied a minimum study duration for inclusion of 1 (Farmer et al., 2001) , 6 (Moore et al., 2004) or 12 (Norris et al., 2004) months.
In all systematic reviews, two investigators performed data extraction. Three systematic reviews reported that in case of missing data the original authors were contacted (Althuis et al., 2002; Moore et al., 2004; Norris et al., 2004) , but it remains unclear whether these attempts were successful. One systematic review reported additional data from one author (Farmer et al., 2001 ), but it remains unclear whether the same effort was made for other missing data.
Internal validity, that is, the quality of included studies, was assessed by the Jadad scale (Farmer et al., 2001; Yeh et al., 2003; Moore et al., 2004) , by the method of Chalmers et al. (1981) (Althuis et al., 2002) , the method recommended by the Cochrane Collaboration (Norris et al., 2004) , or by an own, separately published method (Brown et al., 1996) . But, even though all six systematic reviews reported some form of quality assessment, it was unclear in three systematic reviews how quality data were incorporated in the (weighing of) results (Brown et al., 1996; Althuis et al., 2002; Yeh et al., 2003) . In the other three systematic reviews, the quality data were integrated narratively (Moore et al., 2004) or by sensitivity and meta-regression analyses (Farmer et al., 2001; Norris et al., 2004) . Four systematic reviews reported methods to handle heterogeneity (Farmer et al., 2001; Althuis et al., 2002; Moore et al., 2004; Norris et al., 2004) , the other two did not report or perform an assessment of heterogeneity (Brown et al., 1996; Yeh et al., 2003) . Examples of methods used to assess heterogeneity were: w 2 tests (Farmer et al., 2001; Althuis et al., 2002; Moore et al., 2004) , and subgroup analyses (Farmer et al., 2001 ; Moore Critical appraisal of reviews of diabetic diet Statistical meta-analyses were presented in three systematic reviews (Brown et al., 1996; Farmer et al., 2001; Norris et al., 2004) and planned in two other systematic reviews, but owing to low numbers of included studies results were presented narratively (Althuis et al., 2002; Moore et al., 2004) . One review rated the evidence by using the US Preventive Task Force Criteria and American Diabetes Association Evidence Grading System for clinical recommendations (Yeh et al., 2003) .
Details about external validity are summarized in Table 3 . All but one systematic review reported details of treatment regimens. The setting and the duration of diabetes were the least frequently reported.
Outcomes of the systematic reviews Dietary advice in general. One systematic review focused on dietary advice in general for patients with type 2 diabetes 
Brown et al.
Norris et al.
Althuis et al.
Farmer et al.
Yeh et al. Overall score should be based on the answers to the first nine questions. We used the following guidelines: if the 'no' option was used on question 2, 4, 6 or 8, the review is likely to have major flaws (awarded with a score of 3 or less). 
Yeh et al.
Abbreviation: BMI; body mass index. Information about characteristics of included studies is reported adequately ( þ ) if the information is reducible to individual included studies; (-) ¼ not reported. (Moore et al., 2004) . Eighteen studies were included, but nine of these compared dietary advice with dietary advice and exercise or behavioural interventions. The nine studies on dietary interventions were sub-divided into three comparison groups: an ADA exchange diet versus a reduced fat diet (two studies), a low-fat diet versus a moderate fat or lowcarbohydrate diet (five studies) and very-low-calorie diet versus low-calorie diet (two studies). Statistical meta-analyses could not be performed owing to the low number of studies, heterogeneity and low quality of included studies, thus no conclusions were drawn.
Diet for losing or controlling body weight. In two systematic reviews, diet for the purpose of controlling or losing weight was being studied as a part of a broader research question that also included other interventions for controlling weight (e.g. exercise). A systematic review published in 1996 included 89 studies of which, 40% involved dietary interventions (Brown et al., 1996) , 72% of includes studies were non-experimental (one-group pre-post-test design). In the main meta-analysis, all dietary approaches were considered together and the lengths of the interventions ranged from 'immediate' outcomes to more than 1 year. Dietary interventions (ADA reduced calorie, very-low-calorie diet, protein sparing modified fast diet) lowered body weight by approximately 9 kg (20 lb) and reduced glycated haemoglobin by 2.7%. Another systematic review of more recent date investigated dietary and behavioural interventions to reduce body weight. Twenty-two studies were eligible for inclusion in the meta-analyses. However, pooled results for diet-only studies were sparse. A meta-analysis of two studies compared verylow-calorie diet with low-calorie diets (Norris et al., 2004) , this resulted in a decrease in body weight of 3 kg (95% CI 0.5-6.4) in favour of the very-low-calorie diet. In an additional meta-analyses, the effects of treatment in individual study arms (i.e. pre-test value considered control, posttest value intervention), the effect of 'usual care' was a decrease of 2 kg in body weight (95% CI 0.6-3.5) and lowcalorie diet resulted in a decrease of 3.7 kg (95% CI 2.3-5.1). Details for five out of eight items necessary to assess external validity were missing (Table 3) .
Effects of supplements. Althuis et al. (2002) reviewed the effect of chromium supplements on glucose and insulin concentration. Only four of the included studies were performed in patients with type 2 diabetes. Duration ranged from 8 to 24 weeks and the dosage of chromium ranged from 10.8 mg in yeast to 1000 mg chromium piccolinate. No metaanalyses in this subgroup were performed. No overall result of the systematic review in the type 2 diabetes subgroup was given, as the results of the individual studies were inconclusive. Farmer et al. (2001) performed a systematic review on the efficacy of fish-oil supplementation in patients with type 2 diabetes mellitus. Eighteen studies were included in the review. The dosage of fish-oil ranged from 1.1 to 5.2 g eicosapentaenoic acid and 0.3-4.8 g docosahexaenoic acid, and the control interventions were placebo tablets or vegetable oil. The duration of studies ranged from 3 to 24 weeks. In meta-analyses, the use of fish-oil resulted in a statistically significant decrease in triglycerides of 0.56 mmol/l (14 trials, 95% CI 0.40-0.71) and a statistically significant increase of LDL-cholesterol of 0.24 mmol/l (11 trials, 95% CI 0.05-0.43). No statistically significant effects were found for glycated haemoglobin, fasting glucose, totaland high-density lipoprotein cholesterol and body weight.
Finally, Yeh et al. (2003) reported results of a systematic review on the effects of herbs and dietary supplements. They included 108 trials with 26 different substances that were subdivided into three main groups: single herbs, combination herbs and vitamin/mineral supplements. No statistical meta-analyses were performed. Instead, evidence was rated by using two different sets of criteria as mentioned before. Whether the summarized trials of one certain compound was awarded the highest level of evidence (level 1, level A), did not depend on the quality of the trials. Nor was a 'level 1' label a guarantee for a clear outcome. For example, the conclusions for the substance Coccinia indica (ivy gourd) was that 'the potential role of Coccinia indica warrants further study', which was awarded with the highest level of evidence (I, A). This way, 'preliminary' or 'suggestive' evidence for, or 'potential effects' on glycemic control were found for ginseng, fenugreek, nopal (a cactus species), gymnema sylvestre, momordica charantia, aloe vera, traditional Chinese medicine and vanadium formulas were found. In addition, 'preliminary' evidence for no effect was found for bauhinia forficate, myrcia uniflora and combination formulas in Native American medicine. Inconclusive results were reported for ivy gourd, garlic species, holy basil, fig leaf, milk thistle, combination formulas in Tibetan medicine, chromium, magnesium, L-carnitine and a-lipoic acid. Results for studies with type 1 and type 2 diabetic patients were considered together; however, only four studies were carried out in type 1 diabetic patients.
Discussion
Our review of systematic reviews of diet in patients with type 2 diabetes showed that most systematic reviews resulted in inconclusive findings, and if a statistically significant finding was reported, interpretation was difficult because data necessary to assess external validity were mostly lacking. Therefore, to assess the value of nutritional interventions in type 2 diabetes, systematic reviews are currently not helpful. A 'technical review' such as published by the American Diabetes Association (Franz et al., 2002) may provide a comprehensive overview of the evidence for the different topics in dietary treatment of type 2 diabetes, but it should be noted that such a narrative approach is susceptible for many sources of bias.
Previous studies attempted to review systematic reviews and meta-analyses in the fields of asthma (Jadad et al., 2000) , back and neck pain (Assendelft et al., 1995; Furlan et al., 2001; Hoving et al., 2001) , analgesia and anaesthesia (Jadad and McQuay, 1996; Choi et al., 2001) , emergency medicine (Kelly et al., 2001) and surgery (Dixon et al., 2005) . With no exception, those studies discussed the (predominantly low) quality of systematic reviews. The applicability of the results for practice was not a topic and none of those studies assessed external validity. We are not aware of any comparable study in the field of nutrition.
The results of our exercise have been influenced by factors on three different levels. First, the approach of a systematic overview of systematic reviews has its own strengths and limitations. Second, outcomes are directly influenced by the methodological quality of the included systematic reviews. And finally, the results are influenced in an indirect way by the studies included in the systematic reviews.
Strengths and limitations of a review of systematic reviews Because no clear-cut guidelines for the systematic evaluation of systematic reviews exist, we roughly followed similar methodology as in normal systematic reviews. This means that we tried to reduce selection and detection bias by rigorous methods in defining in-and exclusion criteria, searching of studies, extracting data, quality assessment and combining results. We experienced problems in the assessment of quality, external validity and method of reporting and combining outcomes. With respect to quality assessment, we used the OQAQ, to date the only validated instrument to rate quality of systematic reviews. In addition, we assessed two other important aspects of quality, namely the method of heterogeneity assessment and the method of incorporating quality aspects in the results. The fact that the OQAQ fails to rate those aspects is a drawback of the instrument. Our results showed that the method of incorporation of quality in the results is unclear in three out of seven cases, confirming previous findings that there is substantial room for improvement regarding the incorporation of quality data in the results (de Craen et al., 2005; Moja et al., 2005) . The assessment of external validity was the second problem we encountered. This is an underexposed topic in the appraisal of systematic reviews (Rothwell, 2005) . As there are no accepted guidelines on how external validity of systematic reviews should be assessed, we used a selfdeveloped approach. We found that data necessary to assess external validity are mostly missing, and this hampers the judgment of generalizability of the results. Finally, we had difficulties in establishing the outcomes. Systematic reviews are original research in itself, and should therefore add new information to what is already know. We decided a priori that results from statistical meta-analyses or overall judgment of effectiveness reached by predefined methods should be considered outcomes of a systematic review. Doing so, we only found clear outcomes in the systematic review on fishoil supplements (Farmer et al., 2001) . The other systematic reviews yielded no outcomes (Althuis et al., 2002; Moore et al., 2004) or very limited outcomes of which the external validity remained largely unclear (Brown et al., 1996; Yeh et al., 2003; Norris et al., 2004) .
Quality of included reviews
Overall quality according to the OQAQ was good: five out of seven systematic reviews had minor to minimal flaws. The two studies with low scores on the OQAQ (Brown et al., 1996; Yeh et al., 2003) both failed on the issues of heterogeneity assessment and incorporation of quality in the results, whereas among the other systematic reviews only one study failed on the issue of incorporating quality (Althuis et al., 2002) . The relatively high scores for quality can for a large extend be explained by the inclusion criteria we applied. We decided a priori, that only systematic reviews that reported qto have searched in at least one major database, and that had done a quality assessment were included. Therefore, all systematic reviews automatically scored 'yes' in three out of nine questions in the OQAQ.
Despite those overall good quality scores, it is quite remarkable that the results are mostly inconclusive. One reason might be in the so-called 'stainless steel' law of systematic reviews, that is, the more rigorous the review, the less evidence that an intervention will be effective (Petticrew, 2003) .
Another reason for the inconclusive results might be that, except for the reviews on fish-oil and chromium supplementation, reviews had broad instead of focused research questions resulting in a post hoc division in treatment groups (Brown et al., 1996; Yeh et al., 2003; Moore et al., 2004; Norris et al., 2004) . A more optimal approach in, for example, the systematic review on herbs (Yeh et al., 2003) , would be that each herb would be investigated in a single systematic review. Only that way, sufficient detail and transparence can be achieved.
Quantity and quality of studies included in the systematic reviews It is very difficult to conclude about the quantity and quality of primary studies from an overview of systematic reviews. The number of studies that actually exists, and the method and rigorousness of the selection method determine the quantity of primary studies in systematic reviews. All studies scored 'yes' on the question whether search strategies were reasonably comprehensive. So differences in numbers of included studies will be largely determined by differences in inclusion criteria. The two reviews about dietary advices in general (Moore et al., 2004) and interventions aimed at reducing weight (Norris et al., 2004) included 18 and 22 studies, respectively. This is a relatively low number of studies, especially when one considers the broadness of the topic. The other review on weight loss interventions retrieved 89 studies (Brown et al., 1996) . This difference might be explained by the fact that the latter review included studies of short duration and did not exclude uncontrolled designs. Unfortunately, this review was at high risk for bias (OQAQ score 2) and failed to produce data for the assessment of external validity.
Recommendations for future research
We conclude that currently there is only scarce evidence from systematic reviews for diet in patients with type 2 diabetes. However, this finding should not lead to the conclusion that dietary treatment is useless. After all, absence of evidence does not imply evidence of absence (Altman and Bland, 1995) . To effectively assess the state of the evidence and to identify the needs for new primary studies, we recommend performing systematic reviews with more focused research questions but broader inclusion criteria, such as inclusion of short-term studies and the cautious use of non-randomized studies (Reeves et al., 2005; Summerbell et al., 2005) .
